Hb Arta [beta 45 (CD4) Phe-->Cys]: a new unstable haemoglobin with reduced oxygen affinity in trans with beta-thalassaemia. 1995

G Vassilopoulos, and I Papassotiriou, and E Voskaridou, and A Stamoulakatou, and E Premetis, and J Kister, and M Marden, and N Griffon, and C Poyart, and H Wajcman
First Department of Medicine, Laikon Hospital, Athens, Greece.

The interaction of rare Hb variants with beta(0)-thalassaemia results in a quasihomozygous state where the erythrocytes contain the variant as the only major adult Hb component. Such a situation is a unique model that enables functional studies even in the case of a neutral variant that could not be isolated from Hb A. We report here an unusual patient carrying Hb Arta, a novel Hb variant [beta 45 (CD4) Phe-->Cys], in trans with beta(0)-thalassaemia gene (beta(0) 39). The aminoacid substitution at the critical CD corner of this Hb molecular renders the molecule unstable. In addition, haem is displaced in a position that favours the deoxy (T) conformation of the variant, but less than in Hb Cheverly [beta 45 (CD4) Phe-->Ser], and results in a p50 of 43 mmHg (pH 7.4, 37 degrees C) in the red cells with preservation of cooperativity. Solution studies of the almost pure Hb Arta show a 50% decrease in oxygen affinity and normal cooperativity; the Bohr effect and the interaction with organic phosphates are similar to those of Hb A. Hb Arta retains both normal homo- and heterotropic effects allowing a well-preserved oxygen transport in vivo despite a mild anaemia.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004588 Electrophoresis, Cellulose Acetate Electrophoresis in which cellulose acetate is the diffusion medium. Cellulose Acetate Electrophoreses,Cellulose Acetate Electrophoresis,Electrophoreses, Cellulose Acetate
D005260 Female Females
D006455 Hemoglobins, Abnormal Hemoglobins characterized by structural alterations within the molecule. The alteration can be either absence, addition or substitution of one or more amino acids in the globin part of the molecule at selected positions in the polypeptide chains. Abnormal Hemoglobins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D017086 beta-Thalassemia A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin A synthesis in the heterozygous form (thalassemia minor), which is asymptomatic, while in the homozygous form (thalassemia major, Cooley's anemia, Mediterranean anemia, erythroblastic anemia), which can result in severe complications and even death, hemoglobin A synthesis is absent. Anemia, Cooley's,Anemia, Erythroblastic,Anemia, Mediterranean,Hemoglobin F Disease,Thalassemia Major,Thalassemia Minor,Erythroblastic Anemia,Mediterranean Anemia,Microcytemia, beta Type,Thalassemia Intermedia,Thalassemia Major (beta-Thalassemia Major),Thalassemia Minor (beta-Thalassemia Minor),Thalassemia, beta Type,beta Thalassemia,Anemia, Cooley,Anemia, Cooleys,Anemias, Erythroblastic,Anemias, Mediterranean,Cooley's Anemia,Disease, Hemoglobin F,Intermedia, Thalassemia,Intermedias, Thalassemia,Major, Thalassemia (beta-Thalassemia Major),Majors, Thalassemia (beta-Thalassemia Major),Mediterranean Anemias,Microcytemias, beta Type,Minor, Thalassemia (beta-Thalassemia Minor),Minors, Thalassemia (beta-Thalassemia Minor),Thalassemia Intermedias,Thalassemia Major (beta Thalassemia Major),Thalassemia Majors (beta-Thalassemia Major),Thalassemia Minor (beta Thalassemia Minor),Thalassemia Minors (beta-Thalassemia Minor),Thalassemia, beta,Thalassemias, beta,Thalassemias, beta Type,Type Microcytemia, beta,Type Microcytemias, beta,Type Thalassemia, beta,Type Thalassemias, beta,beta Thalassemias,beta Type Microcytemia,beta Type Microcytemias,beta Type Thalassemia,beta Type Thalassemias

Related Publications

G Vassilopoulos, and I Papassotiriou, and E Voskaridou, and A Stamoulakatou, and E Premetis, and J Kister, and M Marden, and N Griffon, and C Poyart, and H Wajcman
May 2002, Hemoglobin,
G Vassilopoulos, and I Papassotiriou, and E Voskaridou, and A Stamoulakatou, and E Premetis, and J Kister, and M Marden, and N Griffon, and C Poyart, and H Wajcman
February 2002, Hemoglobin,
G Vassilopoulos, and I Papassotiriou, and E Voskaridou, and A Stamoulakatou, and E Premetis, and J Kister, and M Marden, and N Griffon, and C Poyart, and H Wajcman
January 1973, Acta haematologica,
G Vassilopoulos, and I Papassotiriou, and E Voskaridou, and A Stamoulakatou, and E Premetis, and J Kister, and M Marden, and N Griffon, and C Poyart, and H Wajcman
January 2013, Hemoglobin,
G Vassilopoulos, and I Papassotiriou, and E Voskaridou, and A Stamoulakatou, and E Premetis, and J Kister, and M Marden, and N Griffon, and C Poyart, and H Wajcman
September 1989, American journal of hematology,
G Vassilopoulos, and I Papassotiriou, and E Voskaridou, and A Stamoulakatou, and E Premetis, and J Kister, and M Marden, and N Griffon, and C Poyart, and H Wajcman
July 1984, FEBS letters,
G Vassilopoulos, and I Papassotiriou, and E Voskaridou, and A Stamoulakatou, and E Premetis, and J Kister, and M Marden, and N Griffon, and C Poyart, and H Wajcman
January 1994, British journal of haematology,
G Vassilopoulos, and I Papassotiriou, and E Voskaridou, and A Stamoulakatou, and E Premetis, and J Kister, and M Marden, and N Griffon, and C Poyart, and H Wajcman
March 2010, Biochimica et biophysica acta,
G Vassilopoulos, and I Papassotiriou, and E Voskaridou, and A Stamoulakatou, and E Premetis, and J Kister, and M Marden, and N Griffon, and C Poyart, and H Wajcman
July 1994, European journal of haematology,
G Vassilopoulos, and I Papassotiriou, and E Voskaridou, and A Stamoulakatou, and E Premetis, and J Kister, and M Marden, and N Griffon, and C Poyart, and H Wajcman
January 1985, Hemoglobin,
Copied contents to your clipboard!